Visteon Corp (VC) stock
Close on Nov 12, 2026Market cap $1.95BP/E 13.6Yield 0.47%
Earnings
Visteon's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Visteon's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 18, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 22, 2026before the open | $970.00M | +5.8% | $0.19 | $0.19 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 23, 2026before the open | $960.00M | -0.9% | $1.80 | $1.91 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 23, 2026before the open | $954.00M | +2.1% | $1.14 | $1.65 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 19, 2026before the open | $948.00M | +1.0% | $2.67 | $2.96 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 23, 2025before the open | $917.00M | -6.4% | $2.04 | $2.15 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 24, 2025before the open | $969.00M | -4.4% | $2.36 | $2.39 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 24, 2025before the open | $934.00M | +0.1% | $2.36 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 18, 2025before the open | $939.00M | -5.2% | $4.37 | $4.44 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 24, 2024before the open | $980.00M | -3.4% | $1.40 | $2.26 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 25, 2024before the open | $1.01B | +3.2% | $2.54 | $2.54 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 25, 2024before the open | $933.00M | -3.5% | $1.50 | $1.61 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 20, 2024before the open | $990.00M | -7.0% | $12.98 | $13.01 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 26, 2023before the open | $1.01B | -1.2% | $2.32 | $2.35 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023before the open | $983.00M | +15.9% | $0.70 | $1.18 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 27, 2023before the open | $967.00M | +18.2% | $1.18 | $1.25 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 16, 2023before the open | $1.06B | +35.4% | $1.18 | $1.32 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 27, 2022before the open | $1.03B | +62.6% | $1.54 | $1.58 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 28, 2022before the open | $848.00M | – | $0.85 | $1.34 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 28, 2022before the open | $818.00M | – | $0.77 | $1.09 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 17, 2022before the open | $786.00M | – | $1.09 | $1.69 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 28, 2021before the open | $631.00M | – | $0.18 | $0.18 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 29, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 29, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 18, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 29, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Visteon's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| sales | FY2026 | $3.80B – $3.85B | – | New | Oct 22, 2026 |
| sales | FY2026 | $3.63B – $3.83B | $3.63B – $3.83B | Reaffirmed | Apr 23, 2026 |
| adjusted EBITDAnon-GAAP | FY2026 | $370.00M – $410.00M | – | New | Oct 22, 2026 |
| adjusted EBITDAnon-GAAP | FY2026 | $455.00M – $495.00M | $455.00M – $495.00M | Reaffirmed | Apr 23, 2026 |
| adjusted free cash flownon-GAAP | FY2026 | $90.00M – $130.00M | – | New | Oct 22, 2026 |
| adjusted free cash flownon-GAAP | FY2026 | $170.00M – $210.00M | $170.00M – $210.00M | Reaffirmed | Apr 23, 2026 |
Guidance vs results
The last range Visteon gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $3.70B – $3.85B | $3.77BΣ4Q | Within range |
Guidance history
Every forecast Visteon put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 22, 2026 | adjusted EBITDA | FY2026 | $370.00M – $410.00M | New |
| Oct 22, 2026 | adjusted free cash flow | FY2026 | $90.00M – $130.00M | New |
| Oct 22, 2026 | sales | FY2026 | $3.80B – $3.85B | New |
| Apr 23, 2026 | adjusted EBITDA | FY2026 | $455.00M – $495.00M | Reaffirmed |
| Apr 23, 2026 | adjusted free cash flow | FY2026 | $170.00M – $210.00M | Reaffirmed |
| Apr 23, 2026 | sales | FY2026 | $3.63B – $3.83B | Reaffirmed |
| Feb 19, 2026 | adjusted EBITDA | FY2026 | $455.00M – $495.00M | New |
| Feb 19, 2026 | adjusted free cash flow | FY2026 | $170.00M – $210.00M | New |
| Feb 19, 2026 | sales | FY2026 | $3.63B – $3.83B | New |
| Oct 23, 2025 | adjusted EBITDA | FY2025 | $475.00M – $505.00M | New |
| Oct 23, 2025 | adjusted free cash flow | FY2025 | $195.00M – $225.00M | New |
| Oct 23, 2025 | guidance range | FY2025 | $3.70B – $3.85B | New |
| Jul 24, 2025 | Adjusted EBITDA | FY2025 | $475.00M – $505.00M | Raised |
| Jul 24, 2025 | Adjusted free cash flow | FY2025 | $195.00M – $225.00M | Raised |
| Jul 24, 2025 | Sales | FY2025 | $3.70B – $3.85B | Raised |
| Feb 18, 2025 | adjusted EBITDA | FY2025 | $450.00M – $480.00M | New |
| Feb 18, 2025 | adjusted free cash flow | FY2025 | $175.00M – $205.00M | New |
| Feb 18, 2025 | sales | FY2025 | $3.65B – $3.85B | New |
| Oct 24, 2024 | adjusted EBITDA | FY2024 | $465.00M – $480.00M | Raised |
| Oct 24, 2024 | adjusted free cash flow | FY2024 | $165.00M – $185.00M | Raised |
| Oct 24, 2024 | sales | FY2024 | $3.85B – $3.90B | Lowered |
| Jul 25, 2024 | adjusted EBITDA | FY2024 | $455.00M – $475.00M | Lowered |
| Jul 25, 2024 | adjusted free cash flow | FY2024 | $155.00M – $185.00M | Reaffirmed |
| Jul 25, 2024 | sales | FY2024 | $3.85B – $3.95B | New |
| Apr 25, 2024 | adjusted EBITDA | FY2024 | $470.00M – $500.00M | Reaffirmed |
| Apr 25, 2024 | adjusted free cash flow | FY2024 | $155.00M – $185.00M | Reaffirmed |
| Apr 25, 2024 | sales | FY2024 | $4.00B – $4.20B | Reaffirmed |
| Feb 20, 2024 | adjusted EBITDA | FY2024 | $470.00M – $500.00M | New |
| Feb 20, 2024 | adjusted free cash flow | FY2024 | $155.00M – $185.00M | New |
| Feb 20, 2024 | sales | FY2024 | $4.00B – $4.20B | New |
| Oct 26, 2023 | adjusted EBITDA | FY2023 | $415.00M – $445.00M | Raised |
| Oct 26, 2023 | adjusted free cash flow | FY2023 | $115.00M – $165.00M | Reaffirmed |
| Oct 26, 2023 | sales | FY2023 | $3.95B – $4.03B | Lowered |
| Aug 3, 2023 | Adjusted EBITDA | FY2023 | $405.00M – $445.00M | Reaffirmed |
| Aug 3, 2023 | Adjusted Free Cash Flow | FY2023 | $115.00M – $165.00M | Reaffirmed |
| Aug 3, 2023 | sales | FY2023 | $3.95B – $4.15B | Reaffirmed |
| Apr 27, 2023 | Adjusted EBITDA | FY2023 | $405.00M – $445.00M | Reaffirmed |
| Apr 27, 2023 | Adjusted Free Cash Flow | FY2023 | $115.00M – $165.00M | Reaffirmed |
| Apr 27, 2023 | sales | FY2023 | $3.95B – $4.15B | Reaffirmed |
| Feb 16, 2023 | Adjusted EBITDA | FY2023 | $405.00M – $445.00M | New |
| Feb 16, 2023 | Adjusted Free Cash Flow | FY2023 | $115.00M – $165.00M | New |
| Feb 16, 2023 | sales | FY2023 | $3.95B – $4.15B | New |
| Oct 27, 2022 | Adjusted EBITDA | FY2022 | $325.00M – $345.00M | Raised |
| Oct 27, 2022 | Adjusted Free Cash Flow | FY2022 | $30.00M – $70.00M | Lowered |
| Oct 27, 2022 | sales | FY2022 | $3.60B – $3.70B | Raised |
| Jul 28, 2022 | Adjusted EBITDA | FY2022 | $295.00M – $335.00M | Reaffirmed |
| Jul 28, 2022 | Adjusted Free Cash Flow | FY2022 | $85.00M – $115.00M | Reaffirmed |
| Jul 28, 2022 | sales | FY2022 | $3.15B – $3.35B | Reaffirmed |
| Apr 28, 2022 | Adjusted EBITDA | FY2022 | $295.00M – $335.00M | Reaffirmed |
| Apr 28, 2022 | Adjusted Free Cash Flow | FY2022 | $85.00M – $115.00M | Reaffirmed |
| Apr 28, 2022 | sales | FY2022 | $3.15B – $3.35B | New |
| Feb 17, 2022 | Adjusted EBITDA | FY2022 | $295.00M – $335.00M | New |
| Feb 17, 2022 | Adjusted Free Cash Flow | FY2022 | $85.00M – $115.00M | New |
| Feb 17, 2022 | sales | FY2022 | $3.15B – $3.35B | New |
| Oct 28, 2021 | adjusted EBITDA | FY2021 | $165.00M – $175.00M | New |
| Oct 28, 2021 | sales | FY2021 | $2.60B – $2.65B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Visteon filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?